From emerging therapies to earlier intervention and psychosocial support, Dermatology Times looks back at key alopecia areata developments in 2026.
Quiz|Articles|August 13, 2026
GPP Awareness Day Quiz: How Well Do You Know Generalized Pustular Psoriasis?
Author(s)Shannon Heaning, Content Associate
Listen
0:00 / 0:00
Key Takeaways
- A knowledge-check format targets NPPAs managing dermatology patients amid evolving therapies and workflow constraints.
- This edition emphasizes generalized pustular psoriasis, including clinical recognition and differentiation through characteristic presentation.
Test your knowledge of GPP recognition, clinical presentation, complications, and targeted treatment!
Advertisement
Welcome to a NPPA Connect Quiz!
Test your knowledge of the clinical topics, emerging treatments, and practical challenges shaping dermatology care for nurse practitioners and physician associates. In recognition of GPP Awareness Day, this edition focuses on
Do you have a quiz topic or questions to share? Contact editor Shannon Heaning at
Which finding is most characteristic of generalized pustular psoriasis (GPP)?
Which statement best describes the relationship between GPP and plaque psoriasis?
Why can an acute GPP flare require urgent medical attention?
The pustules characteristic of GPP are generally described as:
Which immune pathway has a particularly important role in GPP and is the target of a GPP-specific therapy?
Which medication is an IL-36 receptor antagonist FDA approved for GPP?
As of August 2026, the FDA-approved GPP indication for spesolimab-sbzo includes which population?
Which statement about GPP transmission is accurate?
Advertisement
Related to this article
This review of the latest dermatological studies includes insights on artificial intelligence, interstitial granulomatous dermatitis and atopic dermatitis
Maui Derm NP+PA Fall 2026 brought APPs together for updates spanning inflammatory disease, oncology, emerging therapies, and diagnostic challenges.
Faculty from the Cutaneous Oncology Workshop answer practical questions spanning skin cancer prevention, diagnosis, treatment, and follow-up.
Two new Neutrogena facial sunscreens incorporate bemotrizinol, the first new sunscreen active ingredient added to the US OTC monograph in decades.
This review of the latest dermatological studies includes insights on stem cell therapies for skin rejuvenation, smoke exposure in HS, hair loss in pediatric IBD, and more.
An HS toolbox with wound care, symptom relief, and personal care supplies can help patients stay prepared for unexpected flares.
The inaugural workshop explored skin cancer care from prevention and diagnosis through systemic therapy, radiation, and multidisciplinary management.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
2
Tremfya Meets Primary, Major Secondary Endpoints in Phase 4 STAR Study of Axial PsA
3
From Mechanism to Management: Navigating Male Pattern Hair Loss and New Topical Therapies
4
FAQ: Everything Clinicians (and Their Patients) Want to Know About the Hair Loss Pipeline
5